| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/15/2008 | CA2142370C T cell epitopes of ryegrass pollen allergen |
| 07/10/2008 | WO2008083174A2 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | WO2008083150A2 Methods and vectors for generating asialylated immunoglobulins |
| 07/10/2008 | WO2008082889A2 Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| 07/10/2008 | WO2008082608A2 Interleukin-15 antagonists for the treatment of anemia |
| 07/10/2008 | WO2008082374A2 Carbon nanotube nanobomb |
| 07/10/2008 | WO2008082323A1 Growth stimulating and cell regenerating composition and a method for the production thereof. |
| 07/10/2008 | WO2008081942A1 Diagnosis and treatment of cancer by using anti-prg-3 antibody |
| 07/10/2008 | WO2008081927A1 Method for treating cancer using anticancer agent in combination |
| 07/10/2008 | WO2008081581A1 Foxp3 peptide vaccine |
| 07/10/2008 | WO2008081022A1 Vaccine |
| 07/10/2008 | WO2008081015A1 Treatment of prdc in pigs |
| 07/10/2008 | WO2008081014A2 Process for manufacturing vaccines |
| 07/10/2008 | WO2008081008A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | WO2008080926A1 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells |
| 07/10/2008 | WO2008080628A1 Non-specific immunostimulating agents |
| 07/10/2008 | WO2008080623A2 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 07/10/2008 | WO2008080302A1 NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS |
| 07/10/2008 | WO2008080195A1 Compositions and methods for treating or preventing unwanted immune responses |
| 07/10/2008 | WO2008063982A3 High mannose glycoprotein epitopes |
| 07/10/2008 | WO2008063421A3 Biodegradable t-cell activation device and methods |
| 07/10/2008 | WO2008060371A8 USE OF TGF-β ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| 07/10/2008 | WO2008060367A9 Human antibodies that bind cxcr4 and uses thereof |
| 07/10/2008 | WO2008052798A3 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 07/10/2008 | WO2008046576B1 Use of glucocorticoid antagonists in vaccination |
| 07/10/2008 | WO2008043104A9 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 07/10/2008 | WO2008039408A3 Live bacterial vaccines for viral infection prophylaxis or treatment |
| 07/10/2008 | WO2008034008A3 Kinase inhibitors useful for the treatment of proliferative diseases |
| 07/10/2008 | WO2008030625A3 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp) |
| 07/10/2008 | WO2008027394A3 Constructs for enhancing immune responses |
| 07/10/2008 | WO2008021415A9 Glycan data mining system |
| 07/10/2008 | WO2008019376A3 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 07/10/2008 | WO2008009960A3 Anti-testosterone antibodies |
| 07/10/2008 | WO2008005084A3 Methods to prevent and treat diseases |
| 07/10/2008 | WO2007147001A3 Lyophilized formulations of anti-egfr antibodies |
| 07/10/2008 | WO2007140188A3 Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
| 07/10/2008 | WO2007134050A8 Binding polypeptides with optimized scaffolds |
| 07/10/2008 | WO2007079218A3 Metalloproteinase binding proteins |
| 07/10/2008 | WO2007000342A8 Immunogenic composition |
| 07/10/2008 | WO2002102229A9 Diagnosing tumorigenicity and determining resistance to anticancer therapy |
| 07/10/2008 | US20080167600 Device for delivery of an agent to the eye and other sites |
| 07/10/2008 | US20080167458 Nucleotide sequences coding immunoglobulin specific to cell surface transmembrane receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target |
| 07/10/2008 | US20080167193 In Vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 07/10/2008 | US20080166724 VEGF-Modulated Genes and Methods Employing Them |
| 07/10/2008 | US20080166709 MARKs as Modifiers of the p53 Pathway and Methods of Use |
| 07/10/2008 | US20080166698 Antibodies for cancer therapy and diagnosis |
| 07/10/2008 | US20080166379 Prepared from autologous lymphoma cells transfected with emm55; for canines; the modified cancer cells are highly immunogenic to the host, yet show no toxic side effects |
| 07/10/2008 | US20080166378 Death receptor sensitizing compounds and methods of use therefor |
| 07/10/2008 | US20080166377 Comprising a larval-stage hookworm antigen, an adult-stage hookworm antigen, an aluminum-based (Alhydrogel ) adjuvant |
| 07/10/2008 | US20080166376 Nucleic acids, proteins and vectors containing a nucleotide sequence encoding a full-length or a truncated form of the 60kCRMP gene product of a strain of Chlamydia; vaccines |
| 07/10/2008 | US20080166375 Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166373 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS |
| 07/10/2008 | US20080166372 Live Attenuated Rotavirus Vaccine for Oral Administration |
| 07/10/2008 | US20080166371 HPV31(human papillomavirus) virus-like particles (VLPs); vaccines and drugs for preventing hepatitis |
| 07/10/2008 | US20080166370 Immunogenic Compositions Comprising Multiple Gonococcal Antigens |
| 07/10/2008 | US20080166369 Cholesterol, pullulan and/or mannan, estrogen receptor mixture which binds to Toll-like receptor and stimulates antitumor response from antigen presenting cell; antiproliferative agents; tissue targeted therapy |
| 07/10/2008 | US20080166368 Using microbiocidal peptides to enhance uptake of cytokines, polylysines, polyarginine and/or aluminum hydroxide in antigen presenting cells; stimulating host protection from invading pathogens |
| 07/10/2008 | US20080166367 Custom Vectors for Treating and Preventing Pancreatic Cancer |
| 07/10/2008 | US20080166366 Intracellular Delivery Vehicles |
| 07/10/2008 | US20080166365 Composition For Adjusting Water Quality For Adminstration Of Water Sanitizer Sensitive Medicaments Or Vaccines |
| 07/10/2008 | US20080166364 Conjugated to antibody; thrombospondin receptor targeting |
| 07/10/2008 | US20080166363 Improved targetting |
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | US20080166361 Monoclonal antibody conjugate for targeting 10-boron to tumor cells; boron neutron capture therapy |
| 07/10/2008 | US20080166360 Recombinant pollen protein for use in diagnosis, prevention and treatment of allergies |
| 07/10/2008 | US20080166359 Anticancer agents; mitogen-activated protein kinases (MEK) |
| 07/10/2008 | US20080166358 Quinazoline derivatives and methods of treatment |
| 07/10/2008 | US20080166357 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6) |
| 07/10/2008 | US20080166356 Treating bone disorders resulting in increased trabecular bone formation, decreased osteoblast and osteocyte apoptosis and increased osteoprogenitor differentiation |
| 07/10/2008 | US20080166355 Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon |
| 07/10/2008 | US20080166354 Using monoclonal antibody specific to inhibitor of protease or of a non-proteolytic matrix-degrading enzyme (IPNME) as therapeutic tool in treatment of cell proliferative disorders |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166352 B7 related protein-1specific immunogobulin for use in treatment and prevention of asthma, skin, rheumatic and autoimmune disorders |
| 07/10/2008 | US20080166351 Kit comprising beacizumab and antitumor agents for use in treatment of metastatic colorectal cancer in a human |
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080166349 Method to Inhibit the Propagation of an Undesired Cell Population |
| 07/10/2008 | US20080166348 Pneumococcal vaccine and tumor necrosis factor antibodies; c-reactive protein |
| 07/10/2008 | US20080166347 Human antibodies specific for interleukin 15 (IL-15) |
| 07/10/2008 | US20080166346 Freeze dried monoclonal antibody specific for endothelial growth factor receptors for use treatment of cell proliferative disorders; enhanced storage stability |
| 07/10/2008 | US20080166345 Medicaments comprising gene recombinant antibody against ganglioside gd3 |
| 07/10/2008 | US20080166344 Coadministration of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide and carboplatin; kits |
| 07/10/2008 | US20080166343 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 07/10/2008 | US20080166342 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders |
| 07/10/2008 | US20080166341 Cripto blocking antibodies and uses thereof |
| 07/10/2008 | US20080166340 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapeutics and cancer |
| 07/10/2008 | US20080166339 Inhibition of osteopontin for treatment of relapsing autoimmune disease |
| 07/10/2008 | US20080166338 Il-21 as a regulator of immunoglobin production |
| 07/10/2008 | US20080166337 Nucleotide sequences coding tumor associated differentially-expressed gene-12 (TADG-12) protein (serine protease) for use as tool in tissue targeted cancer therapy |
| 07/10/2008 | US20080166336 CD137 agonists to treat patients with IgE-mediated conditions |
| 07/10/2008 | US20080166325 Method of extensive culture of antigen-specific cytotoxic T cells |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2764852A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | CA2677202A1 Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| 07/10/2008 | CA2674365A1 Foxp3 peptide vaccine |